Interactive Osteoporosis Disease Awareness AR Experience
Created for Biopharmaceutical Client
Link copied!
Participants using Rethink Osteoporosis at ASBMR 2019. The booth mural is AMG156B. This is an augmented reality activity in which participants use an iPad to scan a virtual patient and her skeleton to find touchpoints. There are five touch points: hip; vertebra; wrist; humerus; clavicle. Tapping a touchpoint reveals information about fractures at that location and a question intended to spark discussion with an Amgen RML. This activity debuted at ASBMR 2019 in Orlando, FL.
©2019 Amgen Inc. All rights reserved.
Participants using Rethink Osteoporosis at ASBMR 2019. This is an augmented reality activity in which participants use an iPad to scan a virtual patient and her skeleton to find touchpoints. There are five touch points: hip; vertebra; wrist; humerus; clavicle. Tapping a touchpoint reveals information about fractures at that location and a question intended to spark discussion with an RML. This activity debuted at ASBMR 2019 in Orlando, FL.
©2019. All rights reserved.
Participants using Rethink Osteoporosis at ASBMR 2019. This is an augmented reality activity in which participants use an iPad to scan a virtual patient and her skeleton to find touchpoints. There are five touch points: hip; vertebra; wrist; humerus; clavicle. Tapping a touchpoint reveals information about fractures at that location and a question intended to spark discussion with an RML. This activity debuted at ASBMR 2019 in Orlando, FL.
©2019. All rights reserved.
The project
We designed this medical augmented reality (AR) experience as a quick and fun way to engage bone health specialists with important osteoporosis disease awareness information. Using an iPad, participants reveal a virtual patient. Walking around, they reveal her skeleton and discover common sites of fragility fracture. Clinical questions stimulate conversation with onsite medical liasons and analytics provide our client with post-congress metrics. This medical AR experience launched at ASBMR 2019.
Created for
Biopharmaceutical Client
